nodes	percent_of_prediction	percent_of_DWPC	metapath
Sufentanil—OPRM1—telencephalic ventricle—Parkinson's disease	0.0602	0.178	CbGeAlD
Sufentanil—OPRM1—nerve—Parkinson's disease	0.0379	0.112	CbGeAlD
Sufentanil—OPRD1—forebrain—Parkinson's disease	0.023	0.068	CbGeAlD
Sufentanil—OPRK1—forebrain—Parkinson's disease	0.0221	0.0652	CbGeAlD
Sufentanil—OPRM1—brainstem—Parkinson's disease	0.0163	0.0481	CbGeAlD
Sufentanil—OPRM1—forebrain—Parkinson's disease	0.0157	0.0464	CbGeAlD
Sufentanil—OPRD1—head—Parkinson's disease	0.0132	0.0389	CbGeAlD
Sufentanil—OPRK1—head—Parkinson's disease	0.0127	0.0373	CbGeAlD
Sufentanil—OPRD1—nervous system—Parkinson's disease	0.0125	0.0369	CbGeAlD
Sufentanil—OPRD1—central nervous system—Parkinson's disease	0.012	0.0355	CbGeAlD
Sufentanil—OPRK1—nervous system—Parkinson's disease	0.012	0.0354	CbGeAlD
Sufentanil—OPRK1—central nervous system—Parkinson's disease	0.0115	0.0341	CbGeAlD
Sufentanil—OPRK1—cerebellum—Parkinson's disease	0.0113	0.0333	CbGeAlD
Sufentanil—OPRM1—midbrain—Parkinson's disease	0.0104	0.0306	CbGeAlD
Sufentanil—OPRM1—spinal cord—Parkinson's disease	0.0101	0.0299	CbGeAlD
Sufentanil—OPRD1—brain—Parkinson's disease	0.00956	0.0282	CbGeAlD
Sufentanil—OPRK1—brain—Parkinson's disease	0.00917	0.0271	CbGeAlD
Sufentanil—OPRM1—head—Parkinson's disease	0.009	0.0266	CbGeAlD
Sufentanil—OPRM1—nervous system—Parkinson's disease	0.00853	0.0252	CbGeAlD
Sufentanil—OPRM1—central nervous system—Parkinson's disease	0.00822	0.0242	CbGeAlD
Sufentanil—OPRM1—brain—Parkinson's disease	0.00652	0.0192	CbGeAlD
Sufentanil—CYP3A4—nervous system—Parkinson's disease	0.00348	0.0103	CbGeAlD
Sufentanil—CYP3A4—central nervous system—Parkinson's disease	0.00335	0.00988	CbGeAlD
Sufentanil—Alfentanil—ABCB1—Parkinson's disease	0.00323	0.732	CrCbGaD
Sufentanil—OPRK1—GPCR ligand binding—DRD3—Parkinson's disease	0.0013	0.00198	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—PENK—Parkinson's disease	0.0013	0.00198	CbGpPWpGaD
Sufentanil—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.00126	0.00192	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—VPS35—Parkinson's disease	0.00126	0.00192	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—PENK—Parkinson's disease	0.00125	0.00191	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—GRK5—Parkinson's disease	0.00125	0.0019	CbGpPWpGaD
Sufentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.00124	0.00189	CbGpPWpGaD
Sufentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.00124	0.00188	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—GRM5—Parkinson's disease	0.00122	0.00185	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—GRM4—Parkinson's disease	0.0012	0.00183	CbGpPWpGaD
Sufentanil—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.0012	0.00183	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—GPR37—Parkinson's disease	0.00119	0.00181	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—DGKQ—Parkinson's disease	0.00119	0.00181	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—PDYN—Parkinson's disease	0.00119	0.00181	CbGpPWpGaD
Sufentanil—Fentanyl—ABCB1—Parkinson's disease	0.00118	0.268	CrCbGaD
Sufentanil—OPRK1—GPCR ligand binding—HTR7—Parkinson's disease	0.00118	0.00179	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—DRD2—Parkinson's disease	0.00118	0.00179	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—HTR1A—Parkinson's disease	0.00118	0.00179	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—TAC1—Parkinson's disease	0.00116	0.00176	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—PDYN—Parkinson's disease	0.00115	0.00175	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—PENK—Parkinson's disease	0.00114	0.00173	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—DRD1—Parkinson's disease	0.00114	0.00173	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—GRK5—Parkinson's disease	0.00113	0.00172	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—GRM4—Parkinson's disease	0.00112	0.0017	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—GRM5—Parkinson's disease	0.0011	0.00168	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—DRD3—Parkinson's disease	0.0011	0.00168	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00109	0.00166	CbGpPWpGaD
Sufentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.00108	0.00165	CbGpPWpGaD
Sufentanil—OPRD1—GPCR ligand binding—EDN1—Parkinson's disease	0.00108	0.00164	CbGpPWpGaD
Sufentanil—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.00107	0.00163	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—GRM5—Parkinson's disease	0.00107	0.00162	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—VPS35—Parkinson's disease	0.00106	0.00162	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—PENK—Parkinson's disease	0.00106	0.00161	CbGpPWpGaD
Sufentanil—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.00105	0.0016	CbGpPWpGaD
Sufentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.00105	0.00159	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—DGKQ—Parkinson's disease	0.00104	0.00159	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—GPR37—Parkinson's disease	0.00104	0.00159	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—PDYN—Parkinson's disease	0.00104	0.00159	CbGpPWpGaD
Sufentanil—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.00104	0.00158	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.00103	0.00157	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—GRM4—Parkinson's disease	0.00102	0.00155	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—DRD2—Parkinson's disease	0.000995	0.00152	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—HTR7—Parkinson's disease	0.000995	0.00152	CbGpPWpGaD
Sufentanil—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000986	0.0015	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—PDYN—Parkinson's disease	0.000969	0.00148	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—GRM5—Parkinson's disease	0.000968	0.00147	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—PENK—Parkinson's disease	0.000962	0.00147	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000955	0.00145	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—RIT2—Parkinson's disease	0.000952	0.00145	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—EDN1—Parkinson's disease	0.000943	0.00144	CbGpPWpGaD
Sufentanil—OPRD1—GPCR ligand binding—HTR2A—Parkinson's disease	0.000941	0.00143	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000939	0.00143	CbGpPWpGaD
Sufentanil—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	0.000937	0.00143	CbGpPWpGaD
Sufentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.000915	0.00139	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000907	0.00138	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—GRK5—Parkinson's disease	0.000902	0.00137	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—GRM5—Parkinson's disease	0.000901	0.00137	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000897	0.00137	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—TAC1—Parkinson's disease	0.000884	0.00135	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—GPR37—Parkinson's disease	0.000882	0.00134	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—DGKQ—Parkinson's disease	0.000882	0.00134	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—PDYN—Parkinson's disease	0.00088	0.00134	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—DRD1—Parkinson's disease	0.000866	0.00132	CbGpPWpGaD
Sufentanil—OPRM1—TCR Signaling Pathway—IL6—Parkinson's disease	0.000861	0.00131	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—DRD3—Parkinson's disease	0.000839	0.00128	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—RIT2—Parkinson's disease	0.000835	0.00127	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—HTR2A—Parkinson's disease	0.000825	0.00126	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000823	0.00125	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—GRM5—Parkinson's disease	0.000818	0.00125	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—HTR1A—Parkinson's disease	0.000815	0.00124	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—GRM4—Parkinson's disease	0.000809	0.00123	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000807	0.00123	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—TAC1—Parkinson's disease	0.000802	0.00122	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—EDN1—Parkinson's disease	0.000797	0.00121	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—GRK5—Parkinson's disease	0.000791	0.0012	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—DRD1—Parkinson's disease	0.000787	0.0012	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000787	0.0012	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000784	0.00119	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—TAC1—Parkinson's disease	0.000775	0.00118	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PENK—Parkinson's disease	0.000767	0.00117	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MAG—Parkinson's disease	0.000767	0.00117	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000766	0.00117	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—DRD3—Parkinson's disease	0.000762	0.00116	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—DRD1—Parkinson's disease	0.00076	0.00116	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—DRD2—Parkinson's disease	0.000759	0.00116	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—HTR7—Parkinson's disease	0.000759	0.00116	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—DRD3—Parkinson's disease	0.000736	0.00112	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—HTR1A—Parkinson's disease	0.000714	0.00109	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000712	0.00108	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—GRM4—Parkinson's disease	0.00071	0.00108	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—RIT2—Parkinson's disease	0.000705	0.00107	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—TAC1—Parkinson's disease	0.000704	0.00107	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PDYN—Parkinson's disease	0.000702	0.00107	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—HTR2A—Parkinson's disease	0.000697	0.00106	CbGpPWpGaD
Sufentanil—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	0.000696	0.00106	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000696	0.00106	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—DRD1—Parkinson's disease	0.00069	0.00105	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—HTR7—Parkinson's disease	0.000689	0.00105	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—DRD2—Parkinson's disease	0.000689	0.00105	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000687	0.00105	CbGpPWpGaD
Sufentanil—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000687	0.00105	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PENK—Parkinson's disease	0.000673	0.00102	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MAG—Parkinson's disease	0.000673	0.00102	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—GRK5—Parkinson's disease	0.000669	0.00102	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—DRD3—Parkinson's disease	0.000668	0.00102	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—DRD2—Parkinson's disease	0.000665	0.00101	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—HTR7—Parkinson's disease	0.000665	0.00101	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000665	0.00101	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—GFAP—Parkinson's disease	0.00066	0.001	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—TAC1—Parkinson's disease	0.000655	0.000997	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—GRM5—Parkinson's disease	0.000652	0.000993	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—DRD1—Parkinson's disease	0.000642	0.000978	CbGpPWpGaD
Sufentanil—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	0.000637	0.00097	CbGpPWpGaD
Sufentanil—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000628	0.000956	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000624	0.00095	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—DRD3—Parkinson's disease	0.000622	0.000947	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PDYN—Parkinson's disease	0.000615	0.000937	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—EDN1—Parkinson's disease	0.000608	0.000925	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—HTR7—Parkinson's disease	0.000604	0.00092	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—DRD2—Parkinson's disease	0.000604	0.00092	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—HTR1A—Parkinson's disease	0.000604	0.000919	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—GRM4—Parkinson's disease	0.0006	0.000913	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—TAC1—Parkinson's disease	0.000595	0.000905	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—DRD1—Parkinson's disease	0.000583	0.000888	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000581	0.000884	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—GFAP—Parkinson's disease	0.000579	0.000881	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—GRM5—Parkinson's disease	0.000572	0.000871	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—FGF20—Parkinson's disease	0.000572	0.000871	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MAG—Parkinson's disease	0.000569	0.000866	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PENK—Parkinson's disease	0.000569	0.000866	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—DRD3—Parkinson's disease	0.000565	0.00086	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—DRD2—Parkinson's disease	0.000562	0.000856	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—HTR7—Parkinson's disease	0.000562	0.000856	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—ADORA2A—Parkinson's disease	0.000555	0.000845	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—EDN1—Parkinson's disease	0.000552	0.00084	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—EDN1—Parkinson's disease	0.000533	0.000811	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000532	0.000809	CbGpPWpGaD
Sufentanil—CYP3A4—Biological oxidations—COMT—Parkinson's disease	0.000528	0.000803	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000527	0.000803	CbGpPWpGaD
Sufentanil—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	0.000525	0.0008	CbGpPWpGaD
Sufentanil—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	0.000524	0.000798	CbGpPWpGaD
Sufentanil—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	0.00052	0.000792	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PDYN—Parkinson's disease	0.00052	0.000792	CbGpPWpGaD
Sufentanil—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000518	0.000789	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—INSR—Parkinson's disease	0.000512	0.000779	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—DRD2—Parkinson's disease	0.000511	0.000778	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—HTR7—Parkinson's disease	0.000511	0.000778	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—FGF20—Parkinson's disease	0.000502	0.000764	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—GFAP—Parkinson's disease	0.000489	0.000744	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—ADORA2A—Parkinson's disease	0.000486	0.000741	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—EDN1—Parkinson's disease	0.000484	0.000737	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—FGB—Parkinson's disease	0.000484	0.000737	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—GRM5—Parkinson's disease	0.000483	0.000736	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—HTR2A—Parkinson's disease	0.000483	0.000735	CbGpPWpGaD
Sufentanil—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	0.000483	0.000735	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—HTR1A—Parkinson's disease	0.000481	0.000733	CbGpPWpGaD
Sufentanil—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000476	0.000725	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—TAC1—Parkinson's disease	0.000474	0.000722	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000466	0.00071	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—DRD1—Parkinson's disease	0.000465	0.000708	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—EDN1—Parkinson's disease	0.00045	0.000686	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—DRD3—Parkinson's disease	0.00045	0.000685	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—INSR—Parkinson's disease	0.000449	0.000683	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—FGB—Parkinson's disease	0.000424	0.000646	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—FGF20—Parkinson's disease	0.000424	0.000646	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—HTR2A—Parkinson's disease	0.000423	0.000644	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—HTR1A—Parkinson's disease	0.000422	0.000643	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—ADRBK1—Parkinson's disease	0.00042	0.00064	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—TAC1—Parkinson's disease	0.000416	0.000633	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—ADORA2A—Parkinson's disease	0.000411	0.000626	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—EDN1—Parkinson's disease	0.000409	0.000623	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—DRD1—Parkinson's disease	0.000408	0.000621	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—DRD2—Parkinson's disease	0.000407	0.00062	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—HTR7—Parkinson's disease	0.000407	0.00062	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—DRD3—Parkinson's disease	0.000395	0.000601	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000394	0.0006	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—INSR—Parkinson's disease	0.000379	0.000578	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—ADRBK1—Parkinson's disease	0.000369	0.000561	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—FGB—Parkinson's disease	0.000359	0.000546	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—HTR2A—Parkinson's disease	0.000358	0.000545	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—HTR7—Parkinson's disease	0.000357	0.000544	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—DRD2—Parkinson's disease	0.000357	0.000544	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—HTR1A—Parkinson's disease	0.000357	0.000543	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—TAC1—Parkinson's disease	0.000351	0.000535	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—DRD1—Parkinson's disease	0.000344	0.000525	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—MCCC1—Parkinson's disease	0.000342	0.000521	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ND3—Parkinson's disease	0.000342	0.000521	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—IGF2—Parkinson's disease	0.000341	0.00052	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—DRD3—Parkinson's disease	0.000334	0.000508	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—IGF1R—Parkinson's disease	0.00033	0.000502	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—EDN1—Parkinson's disease	0.000326	0.000496	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—OMD—Parkinson's disease	0.000322	0.00049	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—TALDO1—Parkinson's disease	0.000322	0.00049	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—ADRBK1—Parkinson's disease	0.000312	0.000474	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	0.000305	0.000464	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—HTR7—Parkinson's disease	0.000302	0.000459	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—DRD2—Parkinson's disease	0.000302	0.000459	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—NGF—Parkinson's disease	0.0003	0.000456	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—IGF2—Parkinson's disease	0.000299	0.000456	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GCH1—Parkinson's disease	0.000291	0.000443	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—IGF1R—Parkinson's disease	0.000289	0.00044	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—EDN1—Parkinson's disease	0.000286	0.000435	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—HTR2A—Parkinson's disease	0.000285	0.000434	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—APOE—Parkinson's disease	0.000265	0.000404	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—NGF—Parkinson's disease	0.000263	0.0004	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—DBH—Parkinson's disease	0.000259	0.000395	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GBA—Parkinson's disease	0.000259	0.000395	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—FBP1—Parkinson's disease	0.000259	0.000395	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—IGF2—Parkinson's disease	0.000253	0.000385	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—HTR2A—Parkinson's disease	0.00025	0.000381	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—IGF1R—Parkinson's disease	0.000244	0.000372	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—EDN1—Parkinson's disease	0.000242	0.000368	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—APOE—Parkinson's disease	0.000232	0.000354	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—INS—Parkinson's disease	0.000226	0.000345	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—NGF—Parkinson's disease	0.000222	0.000338	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—HTR2A—Parkinson's disease	0.000211	0.000322	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—INS—Parkinson's disease	0.000199	0.000302	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—APOE—Parkinson's disease	0.000196	0.000299	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—DDC—Parkinson's disease	0.00019	0.00029	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GSTA4—Parkinson's disease	0.00018	0.000274	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CASP3—Parkinson's disease	0.000169	0.000257	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—INS—Parkinson's disease	0.000168	0.000256	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—IL6—Parkinson's disease	0.000168	0.000255	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	0.000162	0.000246	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—MAOB—Parkinson's disease	0.00016	0.000244	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MAPK8—Parkinson's disease	0.000155	0.000236	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CASP3—Parkinson's disease	0.000148	0.000225	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—IL6—Parkinson's disease	0.000147	0.000224	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MAPK8—Parkinson's disease	0.000136	0.000207	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CASP3—Parkinson's disease	0.000125	0.00019	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—IL6—Parkinson's disease	0.000124	0.000189	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	0.000119	0.000181	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CTGF—Parkinson's disease	0.000117	0.000178	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MAPK8—Parkinson's disease	0.000115	0.000175	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	0.000109	0.000166	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—NQO1—Parkinson's disease	0.000108	0.000164	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—TH—Parkinson's disease	0.000106	0.000162	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CYCS—Parkinson's disease	0.000102	0.000155	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—IL6—Parkinson's disease	9.9e-05	0.000151	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—COMT—Parkinson's disease	9.02e-05	0.000137	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GSTP1—Parkinson's disease	8.98e-05	0.000137	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—MAOA—Parkinson's disease	8.96e-05	0.000136	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—HMOX1—Parkinson's disease	8.86e-05	0.000135	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—IL6—Parkinson's disease	8.68e-05	0.000132	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ABCB1—Parkinson's disease	8.5e-05	0.000129	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GSTM1—Parkinson's disease	8.25e-05	0.000126	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GPX1—Parkinson's disease	7.9e-05	0.00012	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—IL6—Parkinson's disease	7.33e-05	0.000112	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—MTHFR—Parkinson's disease	7.29e-05	0.000111	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—APOE—Parkinson's disease	6.79e-05	0.000103	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—INS—Parkinson's disease	5.8e-05	8.83e-05	CbGpPWpGaD
